T. Rowe Price Associates
RVMDW icon

T. Rowe Price Associates’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

T. Rowe Price Associates’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.45M Hold
579,550
– – ﹤0.01% 1524
2026
Q1 		$1.01M Sell
579,550
-16,384
-3% -$31.7K ﹤0.01% 2149
2025
Q4 		$555K Sell
595,934
-1
-0% -$1 ﹤0.01% 2343
2025
Q3 		$179K Sell
595,935
-3,366
-0.6% -$816 ﹤0.01% 2822
2025
Q2 		$162K Hold
599,301
– – ﹤0.01% 2782
2025
Q1 		$23K Sell
599,301
-6,879
-1% -$854 ﹤0.01% 2998
2024
Q4 		$97K Hold
606,180
– – ﹤0.01% 2836
2024
Q3 		$85K Hold
606,180
– – ﹤0.01% 2850
2024
Q2 		$43K Sell
606,180
-1,256
-0.2% -$260 ﹤0.01% 2869
2024
Q1 		$98K Sell
607,436
-1,038
-0.2% -$210 ﹤0.01% 2788
2023
Q4 		$201K Buy
+608,474
New +$272K ﹤0.01% 2544

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

T. Rowe Price Associates's RVMDW Position: Q2 2026 in Review

T. Rowe Price Associates held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 579,550 shares worth $5.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

T. Rowe Price Associates first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • T. Rowe Price Associates held 579,550 shares of Revolution Medicines Inc Warrant worth $5.45M as of Q2 2026.
  • T. Rowe Price Associates left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1524 holding.
  • T. Rowe Price Associates first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.